The largest database of trusted experimental protocols

7 protocols using h89 dihydrochloride

1

Evaluating Desmoplakin Regulation in BeWo Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BeWo cells (0.3 × 105/well; on cover slip in a 24-well plate for desmoplakin I + II staining or 0.1 × 106/well; in a 6-well plate for Western blotting) were seeded overnight. Further, the cells were starved of FBS for at least 4 h before treatment with a pharmacological inhibitor of PKA, H89 dihydrochloride (10 μM; Sigma-Aldrich Inc.) for 1 h at 37 °C with 5% CO2 in humidified air. Subsequently, cells were washed and Ham’s F-12 medium supplemented with 1 × ITS + 1 (Sigma-Aldrich Inc.) and forskolin (25 μM; Sigma-Aldrich Inc.) was added for varying time points. Cells on coverslips were fixed in chilled methanol for 5 min at 4 °C for desmoplakin I + II staining or cell lysates were prepared for Western blotting. Appropriate controls were processed simultaneously.
+ Open protocol
+ Expand
2

Pharmacological Inhibition of Kinases and Histone Deacetylases

Check if the same lab product or an alternative is used in the 5 most similar protocols
H-89 dihydrochloride (PKA/PKB/AKT1 kinase inhibitor), 3-aminobenzoic acid ethyl ester (tricaine), and rifampicin were purchased from Sigma-Aldrich, Zwijndrecht, The Netherlands. H-89 analog 97i was synthesized by the Leiden Academic Center for Drug Research, Division of Medicinal Chemistry, Leiden University, Leiden, The Netherlands. Pan-HDAC inhibitor Trichostatin A (TSA) and class IIa HDAC inhibitors TMP195 and TMP269 were purchased from Selleckchem, Munich, Germany. Hygromycin B was acquired from Life Technologies-Invitrogen, Bleiswijk, The Netherlands. Recombinant human IFN-γ protein was acquired from R&D Systems, Wiesbaden, Germany.
+ Open protocol
+ Expand
3

Comprehensive Compound Procurement for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
H-89 dihydrochloride, D4476, IC261, LY-364947, DAPH 2, nafoxidine hydrochloride, 1,3-di-o-tolylguanidine, naftifine hydrochloride, opipramol, rifampicin, kanamycin, and the library of pharmacologically active compounds (LOPAC) were purchased from Sigma-Aldrich, Zwijndrecht, the Netherlands. Hygromycin B was acquired from Life Technologies-Invitrogen, Bleiswijk, the Netherlands. Imatinib mesylate was from Enzo Life Sciences, Raamsdonksveer, the Netherlands. VEGFR2 kinase inhibitor I and ampicillin were purchased from Calbiochem Merck-Millipore, Darmstadt, Germany. Pazopanib HCl, AT9283, and linifanib (ABT-869) were acquired from Selleck Chemicals, Munich, Germany. Quizartinib was purchased from MedChemExpress, Stockholm, Sweden. Santa Cruz BioTechnology, Heidelberg, Germany was the supplier of PDGFR tyrosine kinase inhibitor III. Dovitinib (TKI-258, CHIR-258) was from APExBIO, Houston, TX, USA. The siKinome library was acquired from Thermo Fisher Dharmacon, Waltham, MA, USA.
+ Open protocol
+ Expand
4

Pharmacological Interventions in Rat Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydrochloric acid (HCl, 867790) was purchased from Carolina Biological Supply Company (Burlington, NC). Perchloric acid (HCLO4, 3752) was purchased from GFS Chemicals (Powell, OH). 3,4-dihy-droxyphenylacetic acid (DOPAC) (850217), dopamine hydrochloride (H8502), desipramine hydrochloride (D3900), 6-OHDA hydrochloride (H4381), Homovanillic acid (HVA) (H1252), bovine serum albumin (BSA) (A2153), L-ascorbic acid (A5960), phorbol 12-myristate 13-acetate (PMA) (16561-29-8), bisindolylmaleimide II (BIM II) (B3056), forskolin (FSK) (F6886) and H-89 dihydrochloride (B1427) were purchased from Sigma Aldrich (St. Louis, MO). Ketoprofen (0215515405) was purchased from MP Biomedicals (Santa Ana, CA). Purified DHA oil was purchased from Nu-Chek Prep (Elysian, MN). All other chemicals used were obtained at the highest available purity from Thermo Fisher Scientific (Waltham, MA) or Sigma-Aldrich (St. Louis, MO). All injections were administered at a volume of 0.001 ml (vehicle) per gram body weight of each rat.
+ Open protocol
+ Expand
5

Pharmacological Modulation of Hs578t Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hs578t WT and KO cells (75,000 cells/well) were seeded in a 6-well plate. Drugs were applied and the cells were incubated overnight (16 h) or for 8 h (for carbenoxolone, PF 431396, IPA-3, and latrunculin A). The final concentrations of the drugs were as follows: meclofenamate sodium (Chem Cruz; #sc200532A) 25 µM; forskolin (Sigma-Aldrich; #F6886), 30 µM; latrunculin A (Tocris; #3973, Bristol, UK), 10 nM; SB203580 (Selleckchem; #S1076, Houston, TX, USA), 25 µM; carbenoxolone (Sigma-Aldrich; #C4790), 25 µM; Y-27632 (Selleckchem; #S1049), 10 µM; IPA-3 (Selleckchem; #S7093), 2.5 µM; 8-Br-cAMP (Abcam; #ab141448, Cambridge, UK), 100 µM; H89 dihydrochloride (Sigma-Aldrich; #C4790), 20 µM; and PF 431396 (Tocris; #4278), 5 µM.
+ Open protocol
+ Expand
6

Inflammatory Pathways and Bile Acid Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inflammatory pathways were induced with Escherichia coli LPS (isotype O26:B6; Sigma‐Aldrich) at concentrations of 0.1, 1, 10 and 100 ng/ml and with mouse IFNγ (Peprotech) 10 and 20 ng/ml. TUDCA sodium salt was purchased from Calbiochem (580549), sodium TLCA from Sigma‐Aldrich (T7515) and HDCA from Alfa Aesar (B20506). In preliminary experiments with Raw264.7 cells, using nitrite release as the inflammatory read out, we tested concentrations of 20–320 µM bile acids, dissolved in cell culture medium. Based on these results we chose 40 µM TLCA, 200 µM TUDCA and 160 µM HDCA in phagocytosis and gene expression assays. The activation of NFκB was inhibited with 2 µM Bay11‐7082 (Sigma‐Aldrich B5556). We blocked CD36 with 25 μM sulfo‐N‐succinimidyl oleate (SSO; Merck SML2148) and PKA with 2 µM H89 dihydrochloride (Sigma‐Aldrich B1427). All‐trans retinoic acid (RA; Sigma‐Aldrich R2625) was used at 0.1 µM and GW4064 (Cayman 10006611‐5) at 2 µM (Wu et al., 2021 (link)).
+ Open protocol
+ Expand
7

Signaling Pathways in Cell Communication

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prostaglandin E2 (PGE2), 3-Isobutyl–1-methyl xanthine (IBMX) and H89 dihydrochloride were purchased from Sigma. Forskolin was purchased from Calbiochem. Tissue culture media and fetal bovine serum were purchased from Hyclone. Antibodies were purchased as follows: rabbit anti-connexin43 (#C6219) antibody was purchased from Sigma; rabbit anti-phospho-CREB (Ser133, #9198), total-CREB (#9197), rabbit anti-phospho-ERK1/2 (Thr202/Tyr404; #9101), rabbit anti-total-ERK1/2 (#9102) and horseradish peroxidase-conjugated secondary antibodies were purchased from Cell Signaling Technology. The mouse anti-GAPDH antibody (#MAB 374) was purchased from Millipore. All other chemicals were purchased from Sigma, unless indicated otherwise.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!